LabCorp(R) Scheduled to Present at the Wachovia Securities Cancer Diagnostics Conference

BURLINGTON, N.C., Feb 23, 2004 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Myla Lai- Goldman, M.D., LabCorp Executive Vice President, Chief Scientific Officer and Medical Director, is scheduled to speak at the

Laboratory Corporation of America(R) Announces 2003 Fourth Quarter and Full Year Results

Strong Quarterly Performance Yields $144.2 Million in Operating Cash Flow; Growth in Operating Income, EBITDA and EPS in Excess of 40 Percent BURLINGTON, N.C., Feb. 12 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the

LabCorp(R) Scheduled to Present at the UBS Global Healthcare Services Conference

BURLINGTON, N.C., Feb. 2 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the UBS Global Healthcare Services Conference in New York, NY on February

LabCorp(R) Scheduled to Present at the U.S. Bancorp Piper Jaffray Healthcare Conference

BURLINGTON, N.C., Jan 27, 2004 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the U.S.

LabCorp(R) Scheduled to Present at the Annual JPMorgan Healthcare Conference

BURLINGTON, N.C., Jan. 9 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the 22nd Annual JPMorgan Healthcare Conference in San Francisco,

LabCorp(R) Announces Stock Repurchase Program

BURLINGTON, N.C., Dec 17, 2003 /PRNewswire-FirstCall via Comtex/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Board of Directors has authorized a stock repurchase program under which LabCorp may purchase up to an aggregate of $250,000,000 of its

LabCorp(R) Names Paul R. Billings, MD, PhD As Vice President National Director of Genetics and Genomics

BURLINGTON, N.C., Oct 27, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) announced today the appointment of Paul R. Billings, MD, PhD, FACP, FACMG, as Vice President National Director of Genetics and Genomics. Dr.

Laboratory Corporation of America(R) Announces 2003 Third Quarter Results

Reports Growth in EPS, Operating Cash Flow and EBITDA in Excess of 25 Percent; EBITDA Margins of 24.5 Percent; Increase in Combined Genomic and Esoteric Testing Revenues of 31 Percent BURLINGTON, N.C., Oct. 23 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH)

LabCorp(R) to Offer Liver Fibrosis Assay HCV FibroSure(TM) Through Exclusive Relationship With BioPredictive

Only Noninvasive Option That Quantifies the Degree and Rate of Liver Fibrosis in HCV Patients BURLINGTON, N.C., Oct 21, 2003 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) and BioPredictive, a French diagnostics firm, today announced an

LabCorp(R) Scheduled to Present at the UBS Global Life Sciences Conference

BURLINGTON, N.C., Sept. 19 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the UBS Global Life Sciences Conference in New York, NY, on September